The energy sensor AMP-activated protein kinases (AMPK) is thought to play an important role in regulating myocardial fatty acid oxidation (FAO) via its phosphorylation and inactivation of acetyl coenzyme A carboxylase (ACC). However, studies supporting this have not directly assessed whether the maintenance of FAO rates and subsequent cardiac function requires AMPK-dependent inhibitory phosphorylation of ACC.
A cetyl coenzyme A carboxylase (ACC) plays an important role in regulating fatty acid oxidation (FAO) in the heart. 1, 2 ACC catalyzes the conversion of acetyl CoA to malonyl-CoA. 3 In muscle, malonyl-CoA is an endogenous inhibitor of carnitine palmitoyl CoA transferase 1, which regulates long-chain fatty acyl CoA import into the mitochondria for β-oxidation. 4, 5 Two isoforms of ACC exist in the heart (ACC 1 and 2), 3, 6 and both ACC1/2 can be regulated by inhibitory phosphorylation by AMP-activated protein kinase (AMPK). 7 AMPK phosphorylates ACC1/2 on serine residues (Ser79/212), [7] [8] [9] leading to inhibition of ACC activity and decreased malonyl-CoA production. 10 Despite the role that AMPK plays in regulating ACC activity and subsequent FAO, whether AMPK-mediated inactivation of ACC plays an obligate role in the maintenance of myocardial FAO rates has not been tested.
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To address this, we generated mutant mice with alanine knock-in mutations in both ACC1 (at Ser79) and ACC2 (at Ser212). In the liver and skeletal muscle, these mice maintain functional ACC and AMPK but express a mutant form of ACC that is no longer inhibited by AMPK phosphorylation. 11 Consistent with the loss of AMPK-mediated inactivation of ACC, we have previously shown that these ACC-double knock-in (ACC-DKI) mice have significantly elevated ACC activity and impaired FAO in the liver. 11 However, the effect of preventing AMPK-mediated phosphorylation of ACC in the heart has not been investigated. Herein, we show that hearts from ACC-DKI mice have increased malonyl-CoA levels compared with wild-type (WT) mice, but their FAO rates are comparable with WT either at baseline or during elevated workloads and after myocardial ischemia; conditions known to result in AMPK-independent 12, 13 and AMPK-dependent metabolic adaptations, 14, 15 respectively. Together, these findings show that during work-induced metabolic adaptations and ischemia-induced AMPK activation, maintenance of myocardial FAO and subsequent cardiac function is not reliant on AMPK-dependent inhibitory phosphorylation of ACC.
Methods

Animals
ACC-DKI mice that express the 2 mutant isoforms of ACC that are resistant to inhibitory phosphorylation by AMPK were described previously. 11 For all experiments, mice of 20 to 33 weeks old were studied; littermate WT mice were used as controls and because there were no sex differences in the parameters measured, both male and female mice were used. The University of Alberta Institutional Animal Care and Use Committee approved all protocols involving mice. An expanded Methods is available in the online-only Data Supplement.
Baseline Echocardiography and Dobutamine Stress Echocardiography
In vivo cardiac function was assessed using transthoracic echocardiography at baseline and at 10 minutes after dobutamine injection as previously described. 16, 17 
Heart Perfusions
For metabolic measurements and ex vivo heart function, hearts were perfused in the working heart mode under normal and high workload conditions, as described previously. 2 For ischemia-reperfusion studies, hearts were aerobically perfused for 30 minutes or aerobically perfused for 30 minutes followed by 18 minutes of global no flow ischemia and 40 minutes of reperfusion, as described previously. 18
Tissue Homogenization and Immunoblot Analysis
Frozen hearts were ground using mortar and pestle, and tissue powder was homogenized in ice-cold lysis buffer. Tissue lysates were resolved by SDS-PAGE, and proteins were transferred onto a nitrocellulose membrane. Blotted proteins were reversibly visualized using MemCode stain (Pierce) and identified using the corresponding primary antibodies. Densitometric analysis was performed using ImageJ software (National Institutes of Health, Bethesda, MD). All densitometric data were corrected against total protein loading visualized via Memcode (Pierce) staining.
Malonyl-CoA Measurements
After heart perfusions, malonyl-CoA was extracted from 20 to 30 mg of frozen ventricular tissue and quantified by ultra-high performance liquid chromatography. 11, 19 Nonstandard Abbreviations and Acronyms Ser212 were mutated to alanines (mutations in red) and ACC1 (ACC1 ΔS79A) and ACC2 (ACC2 ΔS212A) knock-in mice were generated. These 2 strains were crossed to produce ACC-DKI mice. B, Immunoblot analysis of phosphorylated-ACC (P-ACC) and total ACC protein expression. Levels of P-ACC were quantified by densitometry and normalized against total ACC (n=3; *P<0.05). C, Immunoblot analysis of phosphorylated AMP-activated protein kinase (P-AMPK) Thr172 and total AMPK protein expression. Levels of P-AMPK were quantified by densitometry and normalized against total AMPK (n=3). WT indicates wild-type. 
Statistical Analysis
Results are expressed as mean±SEM. Statistical analyses were performed using GraphPad Prism software. Comparisons between 2 groups were made by unpaired 2-tailed Student t test. Comparisons between ≥2 groups were made by 1-way ANOVA and comparisons involving multiple time points are by 2-way ANOVA, respectively. P values of <0.05 were considered statistically significant.
Results
Loss of AMPK-Mediated ACC Phosphorylation in Hearts of ACC-DKI Mice Occurs in the Absence of Any Alterations in Cardiac Function or Morphology
Hearts from ACC-DKI mice ( Figure 1A ) exhibited a lack of ACC phosphorylation on Ser79 (ACC1) and Ser212 (ACC2; Figure 1B ), confirming the lack of inhibitory phosphorylation by AMPK in the heart. This lack of AMPK effect on ACC phosphorylation was not secondary to any changes in levels of AMPK phosphorylation on Thr172 in hearts from either genotypes ( Figure 1C ). Despite the loss of the AMPKmediated ACC phosphorylation, hearts from ACC-DKI mice had normal structure and function in vivo. In fact, hearts from ACC-DKI mice displayed no difference in gross structure ( Figure 2A ), hypertrophy ( Figure 2B ), ejection fraction ( Figure 2C ), isovolumic relaxation time ( Figure 2D ), or other parameters assessed by echocardiography (Table 1) 
Loss of AMPK-Mediated ACC Phosphorylation in Hearts of ACC-DKI Mice Does Not Alter Myocardial FAO Rates
As expected with the loss of AMPK-mediated inhibitory phosphorylation of ACC, malonyl-CoA levels were elevated in ACC-DKI mice compared with controls, both in the ex vivo perfused hearts ( Figure 2E ) and in the in vivo frozen hearts (data not shown). Surprisingly, although we have previously shown that these ACC-DKI mice have impaired FAO rates in the liver, 11 ex vivo perfused hearts from these mice show no differences in myocardial FAO rates ( Figure 2F ) compared with hearts from WT mice. This lack of effect on myocardial FAO rates is consistent with the normal function of these hearts during ex vivo perfusion ( Table 2 ; first two columns).
To determine whether there was a developmental compensation for the chronic ablation of the AMPK phosphorylation sites in ACC, we examined the expression of several proteins involved in regulating cardiac substrate metabolism. There was no significant change in the protein expression of known regulators of FAO, such as adipose triglyceride lipase, cluster of differentiation 36, fatty acid transport protein 1, or peroxisome proliferator-activated receptor α 20-23 ( Figure 3A) . Similarly, there was no change in Akt phosphorylation at both Ser473 and Thr308 sites, p38 phosphorylation at Thr180, or protein kinase A phosphorylation at Thr197 ( Figure 3B ), which are proteins involved in glucose metabolism, [24] [25] [26] as well as in the regulation of FAO. 27, 28 Despite the apparent lack of compensatory responses of important regulators of myocardial energy metabolism in ACC-DKI mice, there was a significant 3.6-fold increase of the uncoupling protein-3 (UCP3) in hearts of ACC-DKI mice compared with the hearts of WT ( Figure 3C ). This is particularly important because UCP3 has been previously shown to increase FAO rates 29, 30 and thus may be responsible for normal FAO rates observed in hearts from ACC-DKI mice despite a disrupted AMPK-ACC signaling axis.
Loss of AMPK-Mediated ACC Phosphorylation in Hearts of ACC-DKI Mice Does Not Alter Myocardial FAO or Function at Elevated Workloads
Because we did not observe any changes in FAO rates in hearts from ACC-DKI mice during normal workloads, we sought to challenge the hearts with increased workload to ascertain their ability to adapt to an acute increase in energy demand. To do this, hearts from WT and ACC-DKI mice were subjected to ex vivo isoproterenol perfusions with elevated afterload pressures to mimic higher workload conditions. This protocol increased workload in hearts from both ACC-DKI and controls by ≈200% ( Figure 4A) , which also increased FAO rates from baseline rates ( Figure 4B , dotted line) in hearts from both genotypes. Of importance, there was no significant difference between the WT and the ACC-DKI mice with regard to heart rate and cardiac power at the elevated workload ( Figure 4C and 4D) . Similarly, in vivo dobutamine stress echocardiography also demonstrated no differences between ACC-DKI mice and controls in terms of heart rate ( Figure 4E ), ejection fraction ( Figure 4F ) or isovolumic relaxation time ( Figure 4G ), or any other echocardiographic parameters (Table 3) . Together, these data support the concept that hearts from ACC-DKI mice are not energetically or functionally compromised at normal or elevated workloads.
Ischemia-Induced Activation of AMPK Does Not Alter Myocardial FAO Rates in Hearts of ACC-DKI Mice
Because ischemia-induced AMPK activation is thought to contribute to FAO dominating as the major source of ATP in the heart during reperfusion, 31 we tested whether preventing the AMPK-dependent inactivation of ACC would limit FAO after ischemia. To do this, we subjected hearts from WT and ACC-DKI mice to 18 minutes of ischemia, ex vivo. After ischemia, hearts were reperfused to measure FAO rates. As expected, hearts from both genotypes demonstrated similar and significant ischemia-induced AMPK activation ( Figure 5A ). This similar degree of AMPK activation also indicates that hearts from both genotypes of mice had equivalent levels of metabolic stress during the ischemic period. Consistent with no change in FAO rates in hearts from ACC-DKI mice compared with hearts from WT at baseline, preventing AMPK-mediated ACC inactivation did not affect FAO rates after ischemia in hearts from ACC-DKI mice ( Figure 5B ). Interestingly, although we observed no changes in myocardial FAO rates in either genotypes, recovery of cardiac function after ischemia was significantly improved in ACC-DKI mice compared with controls ( Figure 5C ; Table 2 ), suggesting a protection from ischemia-induced functional impairment in hearts from ACC-DKI mice.
Discussion
To test the importance of the AMPK-dependent inhibitory phosphorylation of ACC in controlling cardiac FAO and function, we generated ACC-DKI mice and measured their cardiac performance at rest and during a variety of metabolic stresses. We show that in the absence of AMPK-mediated inactivation of ACC, ACC-DKI hearts had a ≈2-fold increase in myocardial malonyl-CoA content compared with hearts from WT mice. These findings demonstrate that the AMPK-ACC signaling axis is essential for controlling malonyl-CoA content in the heart, and that under normal physiological conditions, malonyl-CoA decarboxylase is unable to fully compensate to maintain malonyl-CoA content. Surprisingly, despite strong evidence indicating an important role for malonyl-CoA in the control of FAO, 32, 33 we show that hearts from ACC-DKI Data are mean±SEM of n=7 to 8. ACC-DKI indicates acetyl coenzyme A carboxylase double knock-in; and WT, wild-type. Figure 5 . Ex vivo myocardial energy metabolism and function during ischemia and reperfusion. A, Immunoblot analysis of phosphorylated AMP-activated protein kinases (P-AMPK) Thr172 and total AMPK protein expression. Levels of P-AMPK were quantified by densitometry and normalized against total AMPK (n=3; *P<0.05). B, Palmitate oxidation rates, nmol/g dry wt/min (n=4-5). C, Rate pressure product, heart rate x peak systolic pressure (PSP), mm Hg/min (n=4-5; *P<0.05). ACC-DKI indicates acetyl coenzyme A carboxylase double knock-in; and WT, wild-type. mice have normal rates of FAO and unaltered cardiac structure and function compared with controls. Thus, even though it is firmly established that ACC activity and malonyl-CoA levels are key regulators of myocardial substrate use, 1,2 our findings show that the ability of AMPK to inactivate ACC is not essential for maintaining FAO or cardiac function.
Because we show that AMPK-dependent inactivation of ACC is not essential for the control of myocardial FAO and subsequent cardiac function, we predict that additional mechanisms exist that allow for the maintenance of myocardial FAO rates independent from the AMPK-ACC-malonyl-CoA signaling axis. We also suggest that these additional mechanisms are enhanced in the absence of AMPK-dependent inactivation of ACC and thus allow for easier identification. Consistent with this, we discovered that the protein expression of UCP3 is significantly higher in hearts of ACC-DKI mice compared with hearts of WT mice. Because UCP3 has been previously shown to increase FAO, 29,30 a 3.6-fold compensatory increase in UCP3 expression may contribute to maintain FAO rates in hearts from the ACC-DKI mice. In agreement with UCP3 playing a role in hearts from ACC-DKI mice, higher levels of UCP3 protein expression have previously been shown to protect the heart from ischemia-reperfusion injury 34, 35 as a result of preconditioning. 34 Although we did not observe any differences in myocardial FAO rates after ischemia between genotypes, hearts from ACC-DKI mice demonstrated improved functional recovery after ischemia compared with controls. Although the reason(s) for this unexpected improvement in functional recovery after ischemia in the hearts from ACC-DKI needs further investigation, we speculate that higher expression of UCP3 in hearts from ACC-DKI mice may confer protection from ischemic injury as previously shown. 34, 35 In summary, the data presented herein show for the first time that the AMPK-dependent inhibitory phosphorylation of ACC does not have an obligate role in the regulation of FAO in the healthy or stressed heart. Our findings raise the possibility that there are additional layers of FAO regulation, including upregulation of UCP3, which are enhanced with the disruption of AMPK-dependent inhibitory phosphorylation of ACC. Our data suggest that while an intact AMPK-ACC signaling axis may be sufficient for the control of cardiac FAO, this pathway is not essential. These findings not only have broad implications about the fundamental mechanism involved in the regulation of FAO in the heart but also influence how we interpret how/whether AMPK activation controls myocardial FAO rates during pathological states or whether AMPK activation is beneficial or detrimental to the ischemic heart.
Limitations
One important limitation of this study is that we cannot eliminate possible compensatory developmental changes resulting from the chronic ablation of AMPK signaling to ACC1 and ACC2 that maintain myocardial FAO. Thus, although AMPK-ACC signaling is not essential for regulating myocardial FAO, it may nevertheless be sufficient when present.
